The efficacy of vildagliptin concomitant with insulin therapy in type 2 diabetic subjects.

PMID:25780477
Ito D , Inoue K , Kaneko K , Yanagisawa M , Sumita T , Ikegami Y , Awata T , Ishida H , Katayama S , Inukai K
Journal of clinical medicine research
In Japan, dipeptidyl peptidase 4 (DPP4) inhibitors have become standard therapeutic agents for type 2 diabetes, and numbers of patients receiving insulin therapy combined with DPP4 inhibitors, which is a highly effective regimen, are increasing.


Copyright(C) 2006 BIOIMPACT Co., Ltd. All Rights Reserved